A molecular diagnostics company redefining early breast cancer detection
Syantra is revolutionizing healthcare with their blood test that can identify early breast cancer using epigenetic molecular markers and AI.
Thin Air Labs Contribution:
We initially worked with the team at Syantra to establish a proper board of directors and governance while stabilizing the management team. Over the course of two years, we helped the organization become investment ready and led the first seed round.